Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyoung-Jun Kim

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Psychiatry Investigation|September 16, 2020
"Suicide CARE" (Standardized Suicide Prevention Program for Gatekeeper Intervention in Korea): An UpdateSeon-Cheol Park, Kyoung-Sae Na, Sun-Jung Kwon, et al.
Psychiatry Investigation|November 16, 2020
Contents of the Standardized Suicide Prevention Program for Gatekeeper Intervention in Korea, Version 2.0Kyoung-Sae Na, Seon-Cheol Park, Sun-Jung Kwon, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2022
A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19Yeon-Sook Kim, Seng-Ho Jeon, Junghee Kim, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Psychiatry Investigation|September 16, 2020
"Suicide CARE" (Standardized Suicide Prevention Program for Gatekeeper Intervention in Korea): An UpdateSeon-Cheol Park, Kyoung-Sae Na, Sun-Jung Kwon, et al.
Psychiatry Investigation|November 16, 2020
Contents of the Standardized Suicide Prevention Program for Gatekeeper Intervention in Korea, Version 2.0Kyoung-Sae Na, Seon-Cheol Park, Sun-Jung Kwon, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2022
A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19Yeon-Sook Kim, Seng-Ho Jeon, Junghee Kim, et al.
Pageof 8